X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Sun Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SUN PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SUN PHARMA J.B.CHEMICALS/
SUN PHARMA
 
P/E (TTM) x 14.7 25.3 58.1% View Chart
P/BV x 2.3 3.7 62.9% View Chart
Dividend Yield % 0.2 0.6 26.8%  

Financials

 J.B.CHEMICALS   SUN PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
SUN PHARMA
Mar-17
J.B.CHEMICALS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs318842 37.8%   
Low Rs200572 34.9%   
Sales per share (Unadj.) Rs148.0131.6 112.4%  
Earnings per share (Unadj.) Rs19.132.7 58.4%  
Cash flow per share (Unadj.) Rs23.938.0 63.1%  
Dividends per share (Unadj.) Rs0.503.50 14.3%  
Dividend yield (eoy) %0.20.5 39.0%  
Book value per share (Unadj.) Rs128.9152.7 84.4%  
Shares outstanding (eoy) m84.822,399.26 3.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.75.4 32.5%   
Avg P/E ratio x13.621.6 62.7%  
P/CF ratio (eoy) x10.818.6 58.0%  
Price / Book Value ratio x2.04.6 43.3%  
Dividend payout %2.610.7 24.5%   
Avg Mkt Cap Rs m21,9511,696,877 1.3%   
No. of employees `0002.717.5 15.6%   
Total wages/salary Rs m1,84149,023 3.8%   
Avg. sales/employee Rs Th4,590.918,028.3 25.5%   
Avg. wages/employee Rs Th673.42,798.8 24.1%   
Avg. net profit/employee Rs Th592.14,479.5 13.2%   
INCOME DATA
Net Sales Rs m12,551315,784 4.0%  
Other income Rs m5426,232 8.7%   
Total revenues Rs m13,093322,016 4.1%   
Gross profit Rs m2,055100,893 2.0%  
Depreciation Rs m41212,648 3.3%   
Interest Rs m963,998 2.4%   
Profit before tax Rs m2,08890,479 2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m099 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46912,116 3.9%   
Profit after tax Rs m1,61978,462 2.1%  
Gross profit margin %16.431.9 51.2%  
Effective tax rate %22.513.4 167.8%   
Net profit margin %12.924.8 51.9%  
BALANCE SHEET DATA
Current assets Rs m7,778329,537 2.4%   
Current liabilities Rs m4,358178,870 2.4%   
Net working cap to sales %27.247.7 57.1%  
Current ratio x1.81.8 96.9%  
Inventory Days Days5579 69.2%  
Debtors Days Days8083 96.1%  
Net fixed assets Rs m5,713204,766 2.8%   
Share capital Rs m1702,399 7.1%   
"Free" reserves Rs m10,547363,997 2.9%   
Net worth Rs m10,937366,397 3.0%   
Long term debt Rs m014,361 0.0%   
Total assets Rs m15,574614,102 2.5%  
Interest coverage x22.823.6 96.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.5 156.7%   
Return on assets %11.013.4 82.0%  
Return on equity %14.821.4 69.1%  
Return on capital %20.024.8 80.4%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889NA-   
Fx inflow Rs m6,16944,118 14.0%   
Fx outflow Rs m1,28524,484 5.2%   
Net fx Rs m4,88419,634 24.9%   
CASH FLOW
From Operations Rs m1,39770,822 2.0%  
From Investments Rs m-320-42,216 0.8%  
From Financial Activity Rs m-1,196-22,854 5.2%  
Net Cashflow Rs m-1026,107 -1.7%  

Share Holding

Indian Promoters % 55.4 63.7 87.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 5.1 66.1%  
FIIs % 3.9 23.0 17.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 8.3 445.8%  
Shareholders   30,437 133,026 22.9%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 19, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - FRESENIUS KABI ONCO. COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS